{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID19",
      "Pseudomonas aeruginosa",
      "SARS-CoV-2",
      "TLR5",
      "cystic fibrosis",
      "infection",
      "protease"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34950129",
  "DateCompleted": {
    "Year": "2022",
    "Month": "01",
    "Day": "06"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "01",
    "Day": "06"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "12",
        "Day": "07"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "714027",
      "10.3389/fimmu.2021.714027"
    ],
    "Journal": {
      "ISSN": "1664-3224",
      "JournalIssue": {
        "Volume": "12",
        "PubDate": {
          "Year": "2021"
        }
      },
      "Title": "Frontiers in immunology",
      "ISOAbbreviation": "Front Immunol"
    },
    "ArticleTitle": "Flagellin From <i>Pseudomonas aeruginosa</i> Modulates SARS-CoV-2 Infectivity in Cystic Fibrosis Airway Epithelial Cells by Increasing TMPRSS2 Expression.",
    "Pagination": {
      "StartPage": "714027",
      "MedlinePgn": "714027"
    },
    "Abstract": {
      "AbstractText": [
        "In the coronavirus disease 2019 (COVID-19) health crisis, one major challenge is to identify the susceptibility factors of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) in order to adapt the recommendations for populations, as well as to reduce the risk of COVID-19 development in the most vulnerable people, especially patients with chronic respiratory diseases such as cystic fibrosis (CF). Airway epithelial cells (AECs) play a critical role in the modulation of both immune responses and COVID-19 severity. SARS-CoV-2 infects the airway through the receptor angiotensin-converting enzyme 2, and a host protease, transmembrane serine protease 2 (TMPRSS2), plays a major role in SARS-CoV-2 infectivity. Here, we show that <i>Pseudomonas aeruginosa</i> increases TMPRSS2 expression, notably in primary AECs with deficiency of the ion channel CF transmembrane conductance regulator (CFTR). Further, we show that the main component of <i>P. aeruginosa</i> flagella, the protein flagellin, increases TMPRSS2 expression in primary AECs and Calu-3 cells, through activation of Toll-like receptor-5 and p38 MAPK. This increase is particularly seen in Calu-3 cells deficient for CFTR and is associated with an intracellular increased level of SARS-CoV-2 infection, however, with no effect on the amount of virus particles released. Considering the urgency of the COVID-19 health crisis, this result may be of clinical significance for CF patients, who are frequently infected with and colonized by <i>P. aeruginosa</i> during the course of CF and might develop COVID-19."
      ],
      "CopyrightInformation": "Copyright \u00a9 2021 Ruffin, Bigot, Calmel, Mercier, Givelet, Oliva, Pizzorno, Rosa-Calatrava, Corvol, Balloy, Terrier and Guillot."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Sorbonne Universit\u00e9, Inserm, Centre de Recherche Saint-Antoine (CRSA), Paris, France."
          }
        ],
        "LastName": "Ruffin",
        "ForeName": "Manon",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Sorbonne Universit\u00e9, Inserm, Centre de Recherche Saint-Antoine (CRSA), Paris, France."
          },
          {
            "Identifier": [],
            "Affiliation": "Laboratoire de Parasitologie-Mycologie, APHP, H\u00f4pital Saint-Antoine, Paris, France."
          }
        ],
        "LastName": "Bigot",
        "ForeName": "Jeanne",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Sorbonne Universit\u00e9, Inserm, Centre de Recherche Saint-Antoine (CRSA), Paris, France."
          }
        ],
        "LastName": "Calmel",
        "ForeName": "Claire",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Sorbonne Universit\u00e9, Inserm, Centre de Recherche Saint-Antoine (CRSA), Paris, France."
          }
        ],
        "LastName": "Mercier",
        "ForeName": "Julia",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Sorbonne Universit\u00e9, Inserm, Centre de Recherche Saint-Antoine (CRSA), Paris, France."
          }
        ],
        "LastName": "Givelet",
        "ForeName": "Ma\u00eblle",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "CIRI, Centre International de Recherche en Infectiologie, Team VirPath, Universit\u00e9 de Lyon, Inserm U1111, Universit\u00e9 Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France."
          }
        ],
        "LastName": "Oliva",
        "ForeName": "Justine",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "CIRI, Centre International de Recherche en Infectiologie, Team VirPath, Universit\u00e9 de Lyon, Inserm U1111, Universit\u00e9 Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France."
          }
        ],
        "LastName": "Pizzorno",
        "ForeName": "Andr\u00e9s",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "CIRI, Centre International de Recherche en Infectiologie, Team VirPath, Universit\u00e9 de Lyon, Inserm U1111, Universit\u00e9 Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France."
          }
        ],
        "LastName": "Rosa-Calatrava",
        "ForeName": "Manuel",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Sorbonne Universit\u00e9, Inserm, Centre de Recherche Saint-Antoine (CRSA), Paris, France."
          },
          {
            "Identifier": [],
            "Affiliation": "Pneumologie P\u00e9diatrique, APHP, H\u00f4pital Trousseau, Paris, France."
          }
        ],
        "LastName": "Corvol",
        "ForeName": "Harriet",
        "Initials": "H"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Sorbonne Universit\u00e9, Inserm, Centre de Recherche Saint-Antoine (CRSA), Paris, France."
          }
        ],
        "LastName": "Balloy",
        "ForeName": "Viviane",
        "Initials": "V"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "CIRI, Centre International de Recherche en Infectiologie, Team VirPath, Universit\u00e9 de Lyon, Inserm U1111, Universit\u00e9 Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France."
          }
        ],
        "LastName": "Terrier",
        "ForeName": "Olivier",
        "Initials": "O"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Sorbonne Universit\u00e9, Inserm, Centre de Recherche Saint-Antoine (CRSA), Paris, France."
          }
        ],
        "LastName": "Guillot",
        "ForeName": "Lo\u00efc",
        "Initials": "L"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Switzerland",
    "MedlineTA": "Front Immunol",
    "NlmUniqueID": "101560960",
    "ISSNLinking": "1664-3224"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Bacterial Proteins"
    },
    {
      "RegistryNumber": "12777-81-0",
      "NameOfSubstance": "Flagellin"
    },
    {
      "RegistryNumber": "EC 3.4.21.-",
      "NameOfSubstance": "Serine Endopeptidases"
    },
    {
      "RegistryNumber": "EC 3.4.21.-",
      "NameOfSubstance": "TMPRSS2 protein, human"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Bacterial Proteins"
    },
    {
      "QualifierName": [
        "complications"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cells, Cultured"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cystic Fibrosis"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Flagellin"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "complications"
      ],
      "DescriptorName": "Pseudomonas Infections"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pseudomonas aeruginosa"
    },
    {
      "QualifierName": [
        "metabolism",
        "virology"
      ],
      "DescriptorName": "Respiratory Mucosa"
    },
    {
      "QualifierName": [
        "pathogenicity"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Serine Endopeptidases"
    }
  ],
  "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."
}